PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Engineering, Tufts University, Medford, Massachusetts.\', \'Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.\', \'Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.\', \'Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts.\', \'Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts.\', \'Department of Pharmacy, Emerson Hospital, Concord, Massachusetts.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2021.44942
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 35138402
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all